http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1737828-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e0f4f8190960626ec922a1f03bcd4aba |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-42 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-42 |
| filingDate | 2005-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b554ec6ea6c84341cd3549098a8cc978 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e3de97662346d86a8b559be7893fe853 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1ea4c5395b753d6a389d04184ebcfd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7b61de268792e8c5df9df280841523fc |
| publicationDate | 2007-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-1737828-A1 |
| titleOfInvention | Amorphous magnesium salts of rosuvastatin |
| abstract | The invention provides the novel amorphous rosuvastatin magnesium and process for preparation thereof from crystalline rosuvastatin magnesium, rosuvastatin methyl ammonium salt and from rosuvastatin lactone. Rosuvastatin magnesium is, chemically, (3R,5S,6E)-7-[4-(4-fluorophenyl)-6-(1-methylethyl)-2-[methyl(methylsulfonyl)amino]-5-pyrimidinyl]-3,5-dihydroxy-6-heptenoic acid, magnesium salt (2:1) of Formula (I). Rosuvastatin magnesium is an antihypercholesterolemic drug used in the treatment of atherosclerosis. |
| priorityDate | 2004-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 104.